Madrigal Pharmaceuticals (MDGL) Metrics: History & Chart

Madrigal Pharmaceuticals, Inc.(MDGL)

Biotechnology · West Conshohocken, PA

$496.45+2.83 (+0.57%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.

West Conshohocken, PA

915 employees

www.madrigalpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William J. Sibold

View full financials

Third-Party DCF Estimate (FMP)	$2261.85
Price Gap vs Third-Party Estimate	+362.29%

7D Total Return	-4.53%
30D Total Return	-8.77%
YTD Total Return	-15.24%
1Y Total Return	+11.42%
3Y Total Return	+251.35%
5Y Total Return	+527.88%
10Y Total Return	+3116.28%
15Y Total Return	+347.77%
20Y Total Return	N/A

2026	-15.24%
2025	+88.72%
2024	+33.36%
2023	-20.28%
2022	+242.52%
2021	-23.77%
2020

CAGR TTM	+11.37%
CAGR 3Y	+52.01%
CAGR 5Y	+44.41%
CAGR 10Y	+41.50%
CAGR 15Y	+10.51%
CAGR 20Y	N/A

PE Ratio	1.30
PE Ratio Avg TTM	1.73
PE Ratio Avg 3Y	1.73
Current VS TTM Avg	-25.03%
Current VS 3Y Avg	-25.03%
Current VS 5Y Avg	-25.03%

All Metrics

MDGL Valuation Metrics

MDGL Stock Price Metrics

MDGL Dividend Metrics

MDGL Growth Rate Metrics

MDGL Discounted Cash Flow Metrics

MDGL Returns By Period

MDGL Yearly Returns

MDGL Average Annual Returns By Period (CAGR)

MDGL Revenue Metrics

MDGL PE Ratio Metrics

MDGL PS Ratio Metrics

MDGL PB Ratio Metrics

MDGL Price to Free Cash Flow Ratio Metrics

MDGL Debt to Equity Ratio Metrics

MDGL PEG Ratio Metrics

MDGL FCF Yield

MDGL Earnings Yield

MDGL EBITDA Yield

MDGL OCF Yield

MDGL EV/EBIT Ratio Metrics

MDGL EV/EBITDA Ratio Metrics

MDGL EV/Assets Ratio Metrics

MDGL EV/Sales Ratio Metrics

MDGL Current Ratio Metrics

MDGL Quick Ratio Metrics

MDGL ROIC Metrics

MDGL Return on Assets Metrics

MDGL Return on Equity Metrics

MDGL Net Profit Margin Metrics

MDGL Gross Profit Margin Metrics

MDGL Tax Rate Metrics

PS Ratio	8.87
PS Ratio Avg TTM	13.45
PS Ratio Avg 3Y	29.86
Current VS TTM Avg	-34.04%
Current VS 3Y Avg	-70.29%
Current VS 5Y Avg	-70.29%

PB Ratio	21.75
PB Ratio Avg TTM	21.11
PB Ratio Avg 3Y	13.96
Current VS TTM Avg	+3.04%
Current VS 3Y Avg	+55.78%
Current VS 5Y Avg	+50.59%

PFCF Ratio	5.42
PFCF Ratio Avg TTM	13.87
PFCF Ratio Avg 3Y	13.85
Current VS TTM Avg	-60.93%
Current VS 3Y Avg	-60.87%
Current VS 5Y Avg	-60.87%

Debt/Equity Ratio	0.66
Debt/Equity Ratio Avg TTM	0.52
Debt/Equity Ratio Avg 3Y	0.39
Current VS TTM Avg	+26.58%
Current VS 3Y Avg	+72.05%
Current VS 5Y Avg	+108.21%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	18.46%
FCF Yield Avg TTM	7.62%
FCF Yield Avg 3Y	7.63%
Current VS TTM Avg	+142.29%
Current VS 3Y Avg	+141.91%
Current VS 5Y Avg	+141.91%

Earnings Yield	76.99%
Earnings Yield Avg TTM	66.31%
Earnings Yield Avg 3Y	66.31%
Current VS TTM Avg	+16.10%
Current VS 3Y Avg	+16.10%
Current VS 5Y Avg	+16.10%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	1.16
Ev/Ebit Ratio Avg TTM	1.37
Ev/Ebit Ratio Avg 3Y	1.37
Current VS TTM Avg	-15.53%
Current VS 3Y Avg	-15.53%
Current VS 5Y Avg	-15.53%

Ev/Ebitda Ratio	1.13
Ev/Ebitda Ratio Avg TTM	1.33
Ev/Ebitda Ratio Avg 3Y	1.33
Current VS TTM Avg	-14.86%
Current VS 3Y Avg	-14.86%
Current VS 5Y Avg	-14.86%

Ev/Assets Ratio	9.19
Ev/Assets Ratio Avg TTM	9.19
Ev/Assets Ratio Avg 3Y	7.69
Current VS TTM Avg	-0.03%
Current VS 3Y Avg	+19.44%
Current VS 5Y Avg	+17.50%

Ev/Sales Ratio	8.91
Ev/Sales Ratio Avg TTM	13.52
Ev/Sales Ratio Avg 3Y	29.63
Current VS TTM Avg	-34.11%
Current VS 3Y Avg	-69.93%
Current VS 5Y Avg	-69.93%

Current Ratio	3.20
Current Ratio Avg TTM	3.85
Current Ratio Avg 3Y	5.09
Current VS TTM Avg	-16.81%
Current VS 3Y Avg	-37.00%
Current VS 5Y Avg	-27.87%

Quick Ratio	2.94
Quick Ratio Avg TTM	3.58
Quick Ratio Avg 3Y	4.93
Current VS TTM Avg	-18.01%
Current VS 3Y Avg	-40.44%
Current VS 5Y Avg	-32.41%

ROIC	(37.02%)
ROIC Avg 3Y	(47.00%)
ROIC Avg 5Y	(92.89%)
Current VS 3Y Avg	+21.24%
Current VS 5Y Avg	+60.15%
Current VS 10Y Avg	+39.25%

ROA	(26.12%)
ROA Avg TTM	(5.91%)
ROA Avg 3Y	(8.87%)
Current VS TTM Avg	-342.09%
Current VS 3Y Avg	-194.62%
Current VS 5Y Avg	-55.55%

ROE	(62.07%)
ROE Avg TTM	(50.71%)
ROE Avg 3Y	(54.89%)
Current VS TTM Avg	-22.40%
Current VS 3Y Avg	-13.07%
Current VS 5Y Avg	+28.66%

Net Profit Margin	(25.32%)
Net Profit Margin Avg TTM	(24.82%)
Net Profit Margin Avg 3Y	(21.36%)
Current VS TTM Avg	-2.03%
Current VS 3Y Avg	-18.54%
Current VS 5Y Avg	-104.75%

Gross Profit Margin	91.48%
Gross Pft Margin Avg TTM	92.44%
Gross Pft Margin Avg 3Y	65.21%
Current VS TTM Avg	-1.04%
Current VS 3Y Avg	+40.28%
Current VS 5Y Avg	+126.60%

Tax Rate	108.90%
Tax Rate Avg 3Y	54.45%
Tax Rate Avg 5Y	54.45%
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%
Current VS 10Y Avg	+100.00%